GORDIAN CAPITAL SINGAPORE PTE LTD CRISPR Therapeutics AG Transaction History

GORDIAN CAPITAL SINGAPORE PTE LTD portfolio value:

$0
portfolio value

GORDIAN CAPITAL SINGAPORE PTE LTD quarter portfolio value change:

+7.54%
quarter

CRISPR Therapeutics AG 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -1 shares -1K $65.35 0
Q2 2022 share Increase 0.00% 1 shares 1K $60.77 1